NCT06114758View on ClinicalTrials.gov

Comparison Effectiveness of Rectal Misoprostol & Intravenous Tranexamic Acid Reducing Hemorrhage in Myomectomy

Active, not recruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

September 1, 2023

Primary Completion Date

September 1, 2024

Study Completion Date

November 1, 2024

Conditions

Hemorrhage, SurgicalMyoma;UterusEffect of DrugPostoperative HemorrhagePostoperative Complications

Interventions

DRUG

Cytotec 200Mcg Tablet

the admistiration of 400 Mcg rectal cytotec while starting the surgery, just before the patient is covered

DRUG

Transamine

1 gram intravenous slow infusion intraoperatively as we start the laparatomy

Trial Locations (1)

Unknown

Etlik City Hospital, Ankara

All Listed Sponsors

lead

Ankara Etlik City Hospital

OTHER_GOV

NCT06114758 - Comparison Effectiveness of Rectal Misoprostol & Intravenous Tranexamic Acid Reducing Hemorrhage in Myomectomy | Biotech Hunter | Biotech Hunter